32-Year-Old Oluwatobi Appeals for Help as ₦55m Kidney Transplant Deadline Looms

A 32-year-old Nigerian, Oluwatobi Samuel Oluwaniran, is appealing for urgent help to raise ₦55 million.

Oluwatobi is battling End-Stage Kidney Disease and currently depends on regular dialysis while awaiting a kidney transplant.

His health problems began after severe diabetes complications affected his kidneys. He also lost his sight due to diabetic retinopathy.

Advertisement

Doctors have recommended an urgent kidney transplant as the next major step in his treatment.

The estimated cost covers the transplant, surgery, medication and essential care after the procedure.

So far, about ₦10.49 million has been raised towards the ₦55 million target. However, the family still needs approximately ₦44.51 million to reach the required amount.

Oluwatobi has expressed appreciation to everyone who has contributed towards his treatment so far.

He is also appealing for more support, stressing that every donation can help him move closer to receiving treatment.

A fundraising message shared by his supporters said, “Hi there, I wanted to share a cause that really needs support. Gabriel’s nephew in Lagos has been battling severe kidney disease and now needs a transplant to survive, but the costs have exhausted his private funding. Even a small donation or share can make a big difference in helping him get the treatment he urgently needs—please consider supporting or spreading the word.”

The campaign is calling on individuals, organisations, philanthropists and other well-meaning Nigerians to support him.

Those willing to donate can use the official fundraising page: Support Oluwatobi’s kidney transplant fundraiser

People unable to donate can also help by sharing the appeal with others.

The Oluwatobi kidney transplant fundraiser remains focused on closing the ₦44.51 million funding gap. With continued support, the kidney transplant fundraiser hopes to give him access to the urgent treatment recommended by his doctors.

Add a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement